Continuous Glucose Monitors: A Guide for Primary Care Clinicians
Autor Laura Solanoen Limba Engleză Hardback – 21 noi 2025
With an emphasis on recent developments, it delivers essential insights into emerging CGM technologies, accuracy metrics, and clinical applications. Continuous Glucose Monitors: A Guide for Primary Care Clinicians:
- Covers the most recent CGM devices, including over-the-counter options, and their clinical implications.
- Examines accuracy metrics such as MARD, PARD, and error grids for improved data interpretation.
- Provides guidance on billing, coding, and insurance considerations to streamline clinical implementation.
- Explores CGM efficacy across different populations, including athletes, elderly patients, and individuals with gestational diabetes.
- Discusses barriers to adoption, disparities in access, and the future of CGM technology.
Preț: 1322.94 lei
Preț vechi: 1718.10 lei
-23% Nou
Puncte Express: 1984
Preț estimativ în valută:
234.21€ • 272.72$ • 203.46£
234.21€ • 272.72$ • 203.46£
Carte tipărită la comandă
Livrare economică 19-25 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781041106531
ISBN-10: 104110653X
Pagini: 100
Ilustrații: 44
Dimensiuni: 156 x 234 x 10 mm
Greutate: 0.35 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
ISBN-10: 104110653X
Pagini: 100
Ilustrații: 44
Dimensiuni: 156 x 234 x 10 mm
Greutate: 0.35 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Public țintă
Postgraduate and Undergraduate AdvancedCuprins
Contents
Preface.......................................................................................................................ix
Acknowledgments......................................................................................................x
Chapter 1 History of CGMs..................................................................................1
Chapter 2 Technology .........................................................................................10
Chapter 3 Accuracy.............................................................................................17
Chapter 4 Data Interpretation and Ambulatory Glucose Profile .........................25
Chapter 5 OTC CGMs ........................................................................................32
Chapter 6 Prescription CGM Indications............................................................36
Chapter 7 Efficacy...............................................................................................39
Chapter 8 Billing and Coding .............................................................................46
Chapter 9 Adverse Effects and Interfering Substances.......................................52
Chapter 10 Adoption and Barriers........................................................................56
Chapter 11 Disparities...........................................................................................62
Chapter 12 Insurance Coverage Complexities......................................................64
Chapter 13 Privacy of CGM Data.........................................................................66
Chapter 14 AI + CGM ..........................................................................................70
Chapter 15 Fitness, Athletes, and CGMs..............................................................73
Chapter 16 Research on Psychiatric Effects of CGMs.........................................77
Chapter 17 Controversy ........................................................................................79
Chapter 18 Case Studies .......................................................................................81
Chapter 19 Future Directions................................................................................85
Index........................................................................................................................89
Preface.......................................................................................................................ix
Acknowledgments......................................................................................................x
Chapter 1 History of CGMs..................................................................................1
Chapter 2 Technology .........................................................................................10
Chapter 3 Accuracy.............................................................................................17
Chapter 4 Data Interpretation and Ambulatory Glucose Profile .........................25
Chapter 5 OTC CGMs ........................................................................................32
Chapter 6 Prescription CGM Indications............................................................36
Chapter 7 Efficacy...............................................................................................39
Chapter 8 Billing and Coding .............................................................................46
Chapter 9 Adverse Effects and Interfering Substances.......................................52
Chapter 10 Adoption and Barriers........................................................................56
Chapter 11 Disparities...........................................................................................62
Chapter 12 Insurance Coverage Complexities......................................................64
Chapter 13 Privacy of CGM Data.........................................................................66
Chapter 14 AI + CGM ..........................................................................................70
Chapter 15 Fitness, Athletes, and CGMs..............................................................73
Chapter 16 Research on Psychiatric Effects of CGMs.........................................77
Chapter 17 Controversy ........................................................................................79
Chapter 18 Case Studies .......................................................................................81
Chapter 19 Future Directions................................................................................85
Index........................................................................................................................89
Notă biografică
Laura Solano teaches genetics at A.T. Still University, USA. She graduated from the University of North Texas Health Sciences with a master’s in physician assistant studies. She has practiced faithfully in primary care for over a decade. In 2022, she graduated from A.T. Still University with a Doctorate in Medical Sciences and has published several research and education articles.
Descriere
This book provides an in-depth exploration of Continuous Glucose Monitoring (CGM), covering accuracy metrics, glycemic data interpretation, clinical applications, and recent advancements. It is an essential guide for researchers, clinicians, and students in diabetes management, biomedical science, and engineering.